Gujarat Themis Biosyn Limited has informed the Exchange about Withdrawal of Scheme of Arrangement.
GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn Ltd has withdrawn its proposed merger with Themis Medicare Ltd, which was originally approved by the board on November 18, 2024. The company now plans to independently focus on its core business of fermentation-based pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Management cited new market developments and sees strong opportunities for organic expansion, capacity increases, and potential collaborations or inorganic growth in this space. The board believes standalone focus on core strengths will deliver better value to shareholders. The withdrawal was approved on June 13, 2025, under Clause 21 of the Scheme.
The cancelled merger removes a previously anticipated corporate event, which may cause short-term uncertainty or negative sentiment for investors who were betting on the deal. However, the company's pivot to focus independently on its fermentation and API business, where it sees growth opportunities, could be viewed positively in the medium term if execution delivers results.